Article

Switching From IV to Oral Meds Cuts Healthcare Costs

Switching clinically eligible patients from IV to oral medications can lower the yearly cost of healthcare, according to a recent study published online in Clinical Therapeutics.

Researchers from the Johns Hopkins University School of Medicine in Baltimore reviewed four costly medications and determined that the potential impact on hospital savings could be substantial.

Further details and the abstract are available at: http://www.mdnews.com/news/hd/2011_45/hd_658375

Sources: Clinical Therapeutics, HealthDay, MD News

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Xavier Leleu
Francesco Sparano, MSc
Dr Sundar Jagannath
Richard Lafayette, MD, FACP, Stanford
Eric Lander, MD
Dr Ashley Yocum
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo